The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
127819611 12781961 1 I 20160920 20160927 20160927 EXP JP-ROCHE-1834268 ROCHE KAZUTAKE O, SADAHIRO S, SAITO G, TANAKA A AND SUZUKI T. POSTOPERATIVE ADJUVANT CHEMOTHERAPY FOR STAGE III COLON CANCER-DRUG SELECTION, TOLERABILITY, AND SAFETY IN CLINICAL PRACTICE. JAPANESE JOURNAL OF CANCER AND CHEMOTHERAPY 2016 MAY;43 (5):587-592. 0.00 Y 0.00000 20160927 OT JP JP

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
127819611 12781961 1 PS CAPECITABINE. CAPECITABINE 1 Oral BETWEEN DAY 1 TO 14 U 20896 1000 MG/M**2 BID
127819611 12781961 2 SS OXALIPLATIN. OXALIPLATIN 1 Intravenous (not otherwise specified) ON DAY 1 U 0 130 MG/M**2

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
127819611 12781961 1 Colon cancer stage III
127819611 12781961 2 Colon cancer stage III

Outcome of event

Event ID CASEID OUTC COD
127819611 12781961 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
127819611 12781961 Alanine aminotransferase increased
127819611 12781961 Anaemia
127819611 12781961 Aspartate aminotransferase increased
127819611 12781961 Decreased appetite
127819611 12781961 Diarrhoea
127819611 12781961 Fatigue
127819611 12781961 Hypersensitivity
127819611 12781961 Leukopenia
127819611 12781961 Nausea
127819611 12781961 Neutropenia
127819611 12781961 Palmar-plantar erythrodysaesthesia syndrome
127819611 12781961 Peripheral nerve injury
127819611 12781961 Stomatitis
127819611 12781961 Thrombocytopenia

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

no results found